In vitro susceptibility of Brucella melitensis to new cephalosporins crossing the blood-brain barrier.
AUTOR(ES)
Palenque, E
RESUMO
The in vitro susceptibilities of 83 clinical isolates of Brucella melitensis to seven cephalosporins and a monobactam were determined. Ceftizoxime, ceftriaxone, and cefotaxime were the most effective agents tested, with MICs ranging from 0.25 to 2 micrograms/ml. Moxalactam, cefoperazone, cefuroxime, and ceftazidime showed MICs between 4 and 64 micrograms/ml, with moxalactam being the most active agent in this group. Aztreonam showed poor activity, with MICs higher than 64 micrograms/ml.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=180392Documentos Relacionados
- Rational approaches to breaching the blood-brain barrier.
- Effects of adrenal cortical steroids and osmotic blood-brain barrier opening on methotrexate delivery to gliomas in the rodent: the factor of the blood-brain barrier.
- Transcytotic pathway for blood-borne protein through the blood-brain barrier.
- A method to determine the ability of drugs to diffuse through the blood-brain barrier.
- Isolated microvessels: the blood-brain barrier in vitro.
